In addition, a recent study has demonstrated that IL-32 enhanced the anti-tumor activity by promoting IFN-γ expression in CD8+ T cells, while suppressing the immune responses by inducing Foxp3+ Tregs cells, indicating its contradictory role in the TME of ESCC (85). Here, CD8A is linked to neoplasm.